Effect of unani formulation in PCOS: A case report

Effect of unani formulation in PCOS: A case report

PCOS is the most common endocrine pathology in females of reproductive worldwide. The prevalenceranges between 5% and 15% depending on the diagnostic criteria applied.Its etiology involves both geneticand environmental factors. Typically, women with PCOS show clinical and biochemical hyperandrogenism,oligoanovulation, and micropolycystic morphology of the ovaries. Unani formulation containingNankhwah , Badiyan and Wajturki possessing the properties of Mudirr-i-Bawl-o- Hayd, mujaff -i-Balgham ,Munaffis-i- balgham , Muhallil, Muqawwi-i-Jigar were used in the form of Joshanda 6gm BDStarting from 5 days prior to expected period date to 5 days during menses for 3 cycles, which led to regainregularity of menses, correcting the amount of flow and reducing the ovarian volume on US. Thus unanimedications have the potential to treat ths symtoms of PCOS and improve the quality of life of women.